Benchmark Downgrades Repligen to Hold
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Robert Wasserman has downgraded Repligen (NASDAQ:RGEN) from Buy to Hold, indicating a shift in the stock's outlook.
December 04, 2023 | 4:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Repligen's stock rating has been downgraded by Benchmark from Buy to Hold, suggesting a more cautious view on the stock's future performance.
Downgrades by analysts can lead to a negative perception among investors, potentially causing short-term price declines as market sentiment adjusts to the new rating.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100